We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASFY Launches New World-Scale Plant in France for HMD Production
Read MoreHide Full Article
Key Takeaways
BASFY launches a new world-scale HMD plant in Chalampe, France, supporting its PA 6.6 expansion.
The facility lifts BASFY's annual HMD output capacity to 260,000 metric tons for enhanced supply.
The new research and development laboratory facilitates PA 6.6 research.
BASF SE (BASFY - Free Report) successfully began its operations at the new world-scale hexamethylenediamine (HMD) plant in Chalampe, France. The company began its construction in 2022, aiming to increase BASF’s annual HMD production capacity to 260,000 metric tons.
This facility is a key component of BASF’s expansion of its polyamide (PA) 6.6 business in Europe. BASFY is in the final stage of expanding its PA 6.6 production in Freiburg, Germany.
The investment takes BASF a step forward toward its objective of being the lead supplier for HMD with adequate resources to supply customers with high-quality products. The expanded PA 6.6 polymerization capacity further positions the company well to meet this objective.
HMD, being the precursor to the high-quality production of PA 6.6 polymers and coatings raw materials, has ideally set up its plant in an economic and industrial platform in the Alsace region of France to directly integrate it into the main raw material, adiponitrile. The plant has been installed with a state-of-the-art research and development laboratory as well as corresponding infrastructure to facilitate PA 6.6 research.
BASFY stock has gained 4% over the past year compared with the industry’s 22.4% decline.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.66 per share, implying an 18.6% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.18 per share, indicating a 20.1% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 43.1% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 5% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
BASFY Launches New World-Scale Plant in France for HMD Production
Key Takeaways
BASF SE (BASFY - Free Report) successfully began its operations at the new world-scale hexamethylenediamine (HMD) plant in Chalampe, France. The company began its construction in 2022, aiming to increase BASF’s annual HMD production capacity to 260,000 metric tons.
This facility is a key component of BASF’s expansion of its polyamide (PA) 6.6 business in Europe. BASFY is in the final stage of expanding its PA 6.6 production in Freiburg, Germany.
The investment takes BASF a step forward toward its objective of being the lead supplier for HMD with adequate resources to supply customers with high-quality products. The expanded PA 6.6 polymerization capacity further positions the company well to meet this objective.
HMD, being the precursor to the high-quality production of PA 6.6 polymers and coatings raw materials, has ideally set up its plant in an economic and industrial platform in the Alsace region of France to directly integrate it into the main raw material, adiponitrile. The plant has been installed with a state-of-the-art research and development laboratory as well as corresponding infrastructure to facilitate PA 6.6 research.
BASFY stock has gained 4% over the past year compared with the industry’s 22.4% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Balchem Corporation (BCPC - Free Report) . While AKZOY currently sports a Zacks Rank #1 (Strong Buy), NEM and BCPC carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.66 per share, implying an 18.6% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.18 per share, indicating a 20.1% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 43.1% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 5% in the past year.